CEO Ivan Tornos highlighted that Zimmer Biomet achieved nearly 5% constant currency sales growth in Q4 2024, marking the 12th consecutive quarter of mid-single-digit or better growth. The performance ...

In obesity, Lilly removed a dual amylin calcitonin receptor agonist (DACRA) from its phase 1 pipeline. Lilly got into DACRAs ...

Leidos Holdings, Inc. LDOS is scheduled to release fourth-quarter and full-year 2024 results on Feb. 11, before market open. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.

UPS' (UPS 0.12%) recent fourth-quarter earnings report was monumental. It wasn't so much the numbers from the final quarter ...